0.194
Genprex Inc stock is traded at $0.194, with a volume of 3.04M.
It is down -5.44% in the last 24 hours and down -33.49% over the past month.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
See More
Previous Close:
$0.2052
Open:
$0.206
24h Volume:
3.04M
Relative Volume:
0.35
Market Cap:
$8.32M
Revenue:
-
Net Income/Loss:
$-22.71M
P/E Ratio:
-0.0166
EPS:
-11.71
Net Cash Flow:
$-18.24M
1W Performance:
-5.04%
1M Performance:
-33.49%
6M Performance:
-27.20%
1Y Performance:
-42.74%
Genprex Inc Stock (GNPX) Company Profile
Name
Genprex Inc
Sector
Industry
Phone
512-537-7997
Address
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Compare GNPX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
GNPX
Genprex Inc
|
0.194 | 8.80M | 0 | -22.71M | -18.24M | -11.71 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-26-21 | Initiated | National Securities | Buy |
Apr-29-19 | Initiated | Noble Capital Markets | Outperform |
Genprex Inc Stock (GNPX) Latest News
What institutional flow reveals about Genprex Inc.Market Growth Review & Low Risk High Reward Ideas - newser.com
Will Genprex Inc. stock deliver consistent dividendsWeekly Trend Summary & Community Supported Trade Ideas - newser.com
How to forecast Genprex Inc. trends using time seriesPortfolio Return Report & AI Powered Trade Plan Recommendations - newser.com
How Genprex Inc. stock responds to policy changes2025 EndofYear Setup & Daily Growth Stock Investment Tips - newser.com
Why Genprex Inc. stock is popular among millennials2025 Retail Activity & Target Return Focused Stock Picks - newser.com
Heatmap analysis for Genprex Inc. and competitorsJuly 2025 Catalysts & Growth Focused Entry Point Reports - newser.com
What to expect from Genprex Inc. in the next 30 daysJuly 2025 Breakouts & Long-Term Safe Investment Ideas - newser.com
Is Genprex Inc. still worth holding after the dipQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com
How high can Genprex Inc. stock goMarket Movers & Growth Focused Stock Pick Reports - newser.com
Can Genprex Inc. stock resist market sell offsJuly 2025 Outlook & Long-Term Investment Growth Plans - newser.com
Is Genprex Inc. (2DE0) stock a top hedge fund pickTrade Entry Report & High Conviction Trade Alerts - newser.com
Analyzing net buyer seller activity in Genprex Inc.2025 Sector Review & Growth Oriented Trade Recommendations - newser.com
Risk vs reward if holding onto Genprex Inc.Market Volume Summary & Expert Curated Trade Setups - newser.com
Non-Viral Transfection Reagents Industry Report 2025, with Profiles of Altogen Biosystems, BEX, BTX, Celsion, Genprex, Inovio Pharmaceuticals, MaxCyte, MilliporeSigma, Nepa Gene, OZ Biosciences & MoreResearchAndMarkets.com - FinancialContent
Is Genprex Inc a good long term investmentDividend Stock Watch & Superior Wealth Strategies - earlytimes.in
What analysts say about Genprex Inc stockRetail Investor Activity & Invest Now – Opportunity Window Closing - earlytimes.in
What drives Genprex Inc 2DE0 stock priceIPO Market Watch & Claim Your Custom Stock Report Now - earlytimes.in
Using economic indicators to assess Genprex Inc. potentialEarnings Recap Report & Low Risk Entry Point Tips - newser.com
What drives Genprex Inc stock priceTechnical Breakout Signals & Free Trading Signals to Sharpen Your Edge - Early Times
What the charts say about Genprex Inc. today2025 Technical Overview & Reliable Volume Spike Alerts - newser.com
Does Genprex Inc. fit your quant trading modelTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
Applying Elliott Wave Theory to Genprex Inc.2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Will Genprex Inc. rebound enough to break evenQuarterly Trade Summary & Real-Time Volume Surge Alerts - newser.com
Volatility clustering patterns for Genprex Inc.July 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Can trapped investors hope for a rebound in Genprex Inc.2025 Technical Overview & Accurate Intraday Trade Tips - newser.com
Genprex Inc Stock (GNPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):